1.
Halboos NA, Alasady RA. Assessment of Serum Interleukin-23 as a Biomarker for Diagnosis and Disease Activity Evaluation in Ankylosing Spondylitis Patients. Kufa Jour. Bio. [Internet]. 2025 Aug. 5 [cited 2026 Oct. 15];17(2):138-47. Available from: https://journal.uokufa.edu.iq/index.php/ajb/article/view/20076